SN0

N-(3-CARBOXYPROPANOYL)-L-NORVALINE

Find entries where: SN0

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	N-(3-CARBOXYPROPANOYL)-L-NORVALINE
Identifiers	(2S)-2-[(4-hydroxy-4-oxo-butanoyl)amino]pentanoic acid
Formula	C₉ H₁₅ N O₅
Molecular Weight	217.219
Type	NON-POLYMER
Isomeric SMILES	CCC[C@@H](C(=O)O)NC(=O)CCC(=O)O
InChI	InChI=1S/C9H15NO5/c1-2-3-6(9(14)15)10-7(11)4-5-8(12)13/h6H,2-5H2,1H3,(H,10,11)(H,12,13)(H,14,15)/t6-/m0/s1
InChIKey	HRAPDLBXHOBAKA-LURJTMIESA-N

Chemical Details
Formal Charge	0
Atom Count	30
Chiral Atom Count	1
Bond Count	29
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB08554
Name	N-(3-carboxypropanoyl)-L-norvaline
Groups	experimental
Description	N-(3-carboxypropanoyl)-L-norvaline is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. This medication is known to target n-acetylornithine carbamoyltransferase and putative ornithine carbamoyltransferase.
Synonyms	N-(3-carboxypropanoyl)-L-norvaline

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Putative ornithine carbamoyltransferase	MKKFTCVQDIGDLKSALAESFEIKKDRFKYVELGRNKTLLMIFFNSSLRT...	unknown
N-acetylornithine carbamoyltransferase	MSLKHFLNTQDWSRAELDALLTQAALFKRNKLGSELKGKSIALVFFNPSM...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682